RIA Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$310K Buy
+259
New +$265K 0.07% 118
2024
Q4
Sell
-319
Closed -$282K 144
2024
Q3
$282K Buy
+319
New +$287K 0.1% 101
2024
Q1
$315K Buy
+405
New +$288K 0.13% 95
2023
Q4
Sell
-842
Closed -$452K 154
2023
Q3
$452K Buy
+842
New +$434K 0.2% 66

Other funds holding LLY

RIA Advisory Group's LLY Position: Q2 2026 in Review

RIA Advisory Group opened a new position in Eli Lilly (LLY) in Q2 2026: 259 shares worth $310K. The stake represents 0.07% of the portfolio and ranks #118 among its holdings. This is a return to the name: RIA Advisory Group previously reported a position in LLY as recently as Q3 2024.

RIA Advisory Group first reported a position in LLY in Q3 2023 and has held it in 4 quarters since. The position peaked at $452K in Q3 2023. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • RIA Advisory Group held 259 shares of Eli Lilly worth $310K as of Q2 2026.
  • Eli Lilly was a new RIA Advisory Group position in Q2 2026.
  • Eli Lilly made up 0.07% of RIA Advisory Group's portfolio in Q2 2026, its #118 holding.
  • RIA Advisory Group first reported a position in Eli Lilly in Q3 2023 and has held it in 4 quarters since.
  • RIA Advisory Group's Eli Lilly position peaked at $452K in Q3 2023.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on RIA Advisory Group's 13F filing for Q2 2026, filed 23 Jul 2026.